Concepedia

Publication | Open Access

Interleukin 28B Polymorphism Predicts Pegylated Interferon Plus Ribavirin Treatment Outcome in Chronic Hepatitis C Genotype 4

DOIFull Paper Access

83

Citations

23

References

2011

Year

Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, E. Galmozzi, Luca Valenti, R. Soffredini, Raffaele De Francesco, Gian Maria Prati, Roberta D’Ambrosio, Cristina Cheroni,
Hepatology

Abstract

The IL28B rs12979860 SNP may have an added value in the treatment algorithm of HCV-4 patients because it is the strongest predictor of an SVR to PegIFN/Rbv therapy.

References

YearCitations

Page 1